IRIS
SCUTERI, DAMIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.412
AS - Asia 1.151
EU - Europa 474
SA - Sud America 248
AF - Africa 19
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 7
Totale 3.323
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.366
SG - Singapore 562
CN - Cina 284
IT - Italia 235
BR - Brasile 199
IN - India 109
VN - Vietnam 96
GB - Regno Unito 58
DE - Germania 42
HK - Hong Kong 30
CA - Canada 26
FI - Finlandia 23
SE - Svezia 21
EC - Ecuador 15
MX - Messico 14
AR - Argentina 13
IQ - Iraq 12
NL - Olanda 12
RU - Federazione Russa 12
BD - Bangladesh 11
EE - Estonia 9
FR - Francia 9
PL - Polonia 9
UA - Ucraina 9
ZA - Sudafrica 9
TR - Turchia 8
AT - Austria 7
IE - Irlanda 7
JP - Giappone 7
PE - Perù 7
AU - Australia 6
ES - Italia 6
ID - Indonesia 6
NZ - Nuova Zelanda 6
CO - Colombia 5
RO - Romania 5
TW - Taiwan 5
CL - Cile 4
EU - Europa 4
MA - Marocco 3
NP - Nepal 3
PK - Pakistan 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
HR - Croazia 2
JO - Giordania 2
PY - Paraguay 2
TN - Tunisia 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MU - Mauritius 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
SA - Arabia Saudita 1
SV - El Salvador 1
TG - Togo 1
Totale 3.323
Salva come PNG Salva come JPEG
Città #
San Jose 356
Dallas 170
Singapore 170
Ashburn 169
Santa Clara 98
Bengaluru 89
Hefei 88
Beijing 52
Chandler 48
Ho Chi Minh City 44
Milan 39
Lawrence 38
Princeton 38
London 36
Chicago 33
Hong Kong 30
Hanoi 22
Wilmington 22
São Paulo 21
Catanzaro 19
Los Angeles 18
Munich 18
Helsinki 16
New York 15
Rome 13
Redwood City 12
Des Moines 11
Warsaw 9
Ann Arbor 8
Birmingham 8
Naples 8
Chennai 7
Lima 7
Ottawa 7
Palermo 7
Turku 7
Vallefiorita 7
Brooklyn 6
Council Bluffs 6
Florence 6
Montreal 6
Shenzhen 6
Tokyo 6
Amsterdam 5
Atlanta 5
Boardman 5
Boston 5
Dublin 5
Guangzhou 5
Johannesburg 5
Manchester 5
Phoenix 5
Quito 5
Rio de Janeiro 5
San Francisco 5
St Petersburg 5
The Dalles 5
Washington 5
Assago 4
Auckland 4
Charlotte 4
Mexico City 4
Orem 4
Palizzi Marina 4
San Ferdinando 4
Shanghai 4
Stockholm 4
Taipei 4
Ankara 3
Aversa 3
Baghdad 3
Bogotá 3
Bologna 3
Brasília 3
Catania 3
Curitiba 3
Erbil 3
García 3
Hackney 3
Haiphong 3
Horia 3
Itaquaquecetuba 3
Louisville 3
Mumbai 3
Rende 3
Riobamba 3
Rizziconi 3
Salvador 3
San Nicola Manfredi 3
Springfield 3
Thái Nguyên 3
Toronto 3
Viamão 3
Wuhan 3
Amman 2
Aracaju 2
Asunción 2
Bangkok 2
Barquisimeto 2
Buccinasco 2
Totale 2.001
Salva come PNG Salva come JPEG
Nome #
Effects of Palmitoylethanolamide (PEA) on Nociceptive, Musculoskeletal and Neuropathic Pain: Systematic Review and Meta-Analysis of Clinical Evidence 88
Translational Impact of Genetics and Epigenetics of CGRP System on Chronic Migraine Treatment with Onabotulinumtoxin A and Other Biotech Drugs 83
Benefits and risks associated with cannabis and cannabis derivatives use 79
Pharmacoutilization data-driven artificial intelligence–assisted diagnosis algorithm to improve the pharmacological treatment of pain and agitation in patients suffering from severe dementia 68
Anxiolytic-Like Effects of Bergamot Essential Oil Are Insensitive to Flumazenil in Rats. 68
Efficacy of therapeutic intervention with NanoBEO to manage agitation and pain in patients suffering from severe dementia: a pilot clinical trial 63
Neuropharmacological Properties of the Essential Oil of Bergamot for the Clinical Management of Pain-Related BPSDs. 62
Pain assessment and treatment in dementia at the time of coronavirus disease covid-19 61
Clinical and Market Analysis of NanoBEO: A Public-Worth, Innovative Therapy for Behavioral and Psychological Symptoms of Dementia (BPSD)—Emerging Evidence and Its Implications for a Health Technology Assessment (HTA) and Decision-Making in National Health Systems 57
New Trends in Migraine Pharmacology: Targeting Calcitonin Gene-Related Peptide (CGRP) With Monoclonal Antibodies. 56
Neuropharmacology of the Neuropsychiatric Symptoms of Dementia and Role of Pain: Essential Oil of Bergamot as a Novel Therapeutic Approach. 55
Focus on zavegepant: the first intranasal third-generation gepant 54
Antinociceptive effect of inhalation of the essential oil of bergamot in mice 53
Aging brain: In search for better neurotherapeutics 52
Benefits and risks associated with cannabis and cannabis derivatives use 52
Opioids in Post-stroke Pain: A Systematic Review and Meta-Analysis 52
Impact of nutraceuticals on glaucoma: A systematic review 51
Antispasmodic Effect of Bergamot Essential Oil on Rat Isolated Gut Tissues 49
Evidence on the neuroprotective properties of brimonidine in glaucoma 47
Efficacy and safety of mAbs anti-CGRP/CGRP R (eptinezumab and erenumab) or atogepant in combination with onabotulinumtoxinA in refractory chronic migraine: a clinical trial protocol 46
Aromatherapy and Aromatic Plants for the Treatment of Behavioural and Psychological Symptoms of Dementia in Patients with Alzheimer's Disease: Clinical Evidence and Possible Mechanisms 46
New trends in pain research: from basic research to clinical translation 46
Role of 5-HT1A receptor in the anxiolytic-relaxant effects of bergamot essential oil in rodent 46
Effects of Aging on Formalin-Induced Pain Behavior and Analgesic Activity of Gabapentin in C57BL/6 Mice 44
Pattern of triptans use: A retrospective prescription study in Calabria, Italy 44
Proposal of combination therapies to treat refractory chronic migraine 44
Comparing eptinezumab with onabotulinumtoxinA in the treatment of chronic migraine: a real-world evidence study 44
Analgesic Characteristics of NanoBEO Released by an Airless Dispenser for the Control of Agitation in Severe Dementia 42
Bergamot Essential Oil Attenuates Anxiety-Like Behaviour in Rats 42
2-pentadecyl-2-oxazoline prevents cognitive and social behaviour impairments in the Amyloid β-induced Alzheimer-like mice model: Bring the α2 adrenergic receptor back into play 41
Genetic variants of CGRP signaling pathway in migraine: impact on novel therapeutics 41
The need for better access to pain treatment: learning from drug consumption trends in the USA. 40
Combination of anti-CGRP/CGRP-R mAbs with onabotulinumtoxin A as a novel therapeutic approach for refractory chronic migraine: a retrospective study of real-world clinical evidence and a protocol for a double-blind, randomized clinical trial to establish the efficacy and safety 40
Contribution of Histamine to Nociceptive Behaviors Induced by Intrathecally Administered Cholecystokinin-8 39
Efficacy of Essential Oils in Relieving Cancer Pain: A Systematic Review and Meta-Analysis 38
Pattern of treatment of behavioural and psychological symptoms of dementia and pain: evidence on pharmacoutilization from a large real-world sample and from a centre for cognitive disturbances and dementia 38
Bergamot rehabilitation AgaINst agitation in dementia (BRAINAID): Study protocol for a randomized, double-blind, placebo-controlled trial to assess the efficacy of furocoumarin-free bergamot loaded in a nanotechnology-based delivery system of the essential oil in the treatment of agitation in elderly affected by severe dementia 38
Biphasic Hormetic-like Effect of Lebecetin, a C-type Lectin of Snake Venom, on Formalin-induced Inflammation in Mice 37
Is there a rational basis for cannabinoids research and development in ocular pain therapy? A systematic review of preclinical evidence 37
Behavioral Effects of Continuously Administered Bergamot Essential Oil on Mice With Partial Sciatic Nerve Ligation 37
Basic, Translational, and Clinical Research on Dementia 36
Essential oils for the control of the neuropsychiatric symptoms of dementia. A pharmacotechnological appraisal 36
Eptinezumab for the treatment of migraine 36
Development and translation of nanobeo, a nanotechnology-based delivery system of bergamot essential oil deprived of furocumarins, in the control of agitation in severe dementia 36
Dementia and COVID-19: A Case Report and Literature Review on Pain Management 35
Pharmacokinetic interactions between herbal medicines and drugs: Their mechanisms and clinical relevance 35
Editorial: “Novel Pain Therapeutics: From Basic Research to Clinical Translation and Rehabilitation” 35
New trends in pharmacological control of neuropsychiatric symptoms of dementia 35
CB1R, CB2R and TRPV1 expression and modulation in in vivo, animal glaucoma models: A systematic review 35
Aromatherapy in Stroke Patients: Is it Time to Begin? 34
Safety of Onabotulinumtoxin A in Chronic Migraine: A Systematic Review and Meta-Analysis of Randomized Clinical Trials 33
Pooled Analysis of Real-World Evidence Supports Anti-CGRP mAbs and OnabotulinumtoxinA Combined Trial in Chronic Migraine 33
Preclinical Characterization of Antinociceptive Effect of Bergamot Essential Oil and of Its Fractions for Rational Translation in Complementary Therapy 32
Aging Brain: In Search of Better Neurotherapeutics 32
Evidence for accuracy of pain assessment and painkillers utilization in neuropsychiatric symptoms of dementia in Calabria region, Italy 32
Effect of genotype on individual response to the pharmacological treatment of glaucoma: a systematic review and meta-analysis 31
Essential oils-induced analgesia and related translation for the management of agitation in dementia 31
TRANSLATION OF BERGAMOT ESSENTIAL OIL IN CLINICAL TRIAL FOR CONTROL OF BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA 31
Efficacy of essential oils in pain: A systematic review and meta-analysis of preclinical evidence 31
Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy 31
Requirements for Translation in Clinical Trials of Aromatherapy: The Case of the Essential Oil of Bergamot (BEO) for Management of Agitation in Severe Dementia 31
Translational Value of the Transdermal Administration of Bergamot Essential Oil and of Its Fractions 30
Targeting Neuroplasticity for the Management of Pain and Agitation in Alzheimer’s Disease via Bergamot Nanotherapy 30
Pain and agitation treatment in severe dementia patients: The need for Italian Mobilization–Observation–Behavior–Intensity–Dementia (I-MOBID2) pain scale translation, adaptation and validation with psychometric testing 30
Pharmacotechnological Advances for Clinical Translation of Essential Oils for the Treatment of Pain and Agitation in Severe Dementia 29
Scopolamine-Induced Memory Impairment in Mice: Effects of PEA-OXA on Memory Retrieval and Hippocampal LTP 29
Effect of gabapentin in a neuropathic pain model in mice overexpressing human wild-type or human mutated torsin a 29
Exploitation of thermal sensitivity and hyperalgesia in a mouse model of dystonia 29
Homo-AMPA in the periaqueductal grey modulates pain and rostral ventromedial medulla activity in diabetic neuropathic mice 29
Evaluation of putative differences in vessel density and flow area in normal tension and high-pressure glaucoma using OCT-angiography 28
ROBOCOP (ROBOtic Care of Poststroke Pain): Study Protocol for a Randomized Trial to Assess Robot-Assisted Functional and Motor Recovery and Impact on Poststroke Pain Development 28
PEA-OXA ameliorates allodynia, neuropsychiatric and adipose tissue remodeling induced by social isolation 28
Opioids Resistance in Chronic Pain Management 28
Real world considerations for newly approved CGRP receptor antagonists in migraine care 27
Pharmacological Treatment of Pain and Agitation in Severe Dementia and Responsiveness to Change of the Italian Mobilization-Observation-Behavior-Intensity-Dementia (I-MOBID2) Pain Scale: Study Protocol 27
Unbiased research is needed for rational translation of essential oils in clinic 27
NAbiximols Clinical Translation To the treatment of Pain and Agitation In Severe Dementia (NACTOPAISD): Clinical trial protocol 26
Role of Spinal Cholecystokinin Octapeptide, Nociceptin/Orphanin FQ, and Hemokinin-1 in Diabetic Allodynia 26
Hericenone C attenuates the second phase of formalin-induced nociceptive behavior by suppressing the accumulation of CD11c-positive cells in the paw epidermis via phosphorylated P65 26
Motor behavior induced by bergamot essential oil in experimental tasks is differentially modulated by pretreatment with metabotropic glutamate receptor 2/3 or 5 antagonists 26
GABAA/Benzodiazepine Receptor Complex in the Dorsal Hippocampus Mediates the Effects of Chrysin on Anxiety-Like Behaviour in Female Rats 26
Dementia therapeutics and cognitive rehabilitation 25
Progress in the Treatment of Migraine Attacks: From Traditional Approaches to Eptinezumab 25
Diabetic retinopathy and age-related macular degeneration: a survey of pharmacoutilization and cost in Calabria, Italy. 24
Transgenic Mice for the Translational Study of Neuropathic Pain and Dystonia 21
Editorial: Plant secondary metabolites: Potential therapeutic implications in neuropsychiatric disorders 20
Exploitation of Autophagy Inducers in the Management of Dementia: A Systematic Review 18
Epigenetic and nanotechnology alliance to fight stroke-induced brain damage 17
Gas Chromatography–Mass Spectroscopy (GC-MS) Simultaneous Determination of Limonene, Linalool, and Linalyl Acetate in Rat Plasma Following Transdermal Administration of the Essential Oil of Bergamot Loaded Onto Solid Lipid Nanoparticles (NanoBEO) 10
Risk factors associated to disability in primary headaches: a systematic review to inform future iterations of the Global Burden of Disease Study 8
Epigenetics in migraine: the Junior Editorial Board Members’ vision 6
Positioning rimegepant in migraine prophylaxis: updated evidence and emerging perspectives 1
Totale 3.454
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.394
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.394
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/2022122 4 1 2 13 5 22 9 21 6 15 23 1
2022/2023229 78 9 7 9 17 30 6 21 23 8 17 4
2023/2024194 44 18 14 10 14 45 7 6 4 5 24 3
2024/2025908 125 58 35 21 87 104 20 18 157 44 82 157
2025/20261.876 86 314 198 280 190 77 261 131 205 108 26 0
Totale 3.454